Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and gene therapies
Touchlight extends funding round to US$125M as demand for its dbDNA™ grows rapidly
Biotech Week Boston
Join us at Cell & Gene Therapy, part of Biotech Week Boston (Sep 27-30, 2022).
We’ll be available on Booth 133 to discuss your requirements for advanced therapy manufacturing.
Visit us and learn how our doggybone DNA can be used to enable faster, safer and more scalable DNA production than other traditional methods without contamination of the plasmid DNA backbone.